🔍

Fairchem Organics Limited (FAIRCHEMOR)

₹767.35 +1.16% last close, 16 Oct

📊 NSE: FAIRCHEMOR 🏢 Chemicals 📢 Latest filing: 10 Oct 2026 📝 Analysis written: 13 Dec 2025

Q2 FY27 results

📅 Next results: 22 Oct 2026 (board meeting)

Fairchem Organics Limited's board meets on 22 Oct 2026 to consider its Q2 FY27 results (July-September 2026).

In its latest reported quarter, Q1 FY27, Fairchem Organics' revenue was ₹176 Cr (+34.4% year on year, +50.6% on the previous quarter), and net profit ₹10.0 Cr (+755.9% year on year); the operating margin was 10.1%.

Q1 FY27 (₹ Cr)	Value	YoY vs Q1 FY26	QoQ
Revenue	₹176	+34.4%	+50.6%
Operating profit	₹17.9	+241.6%	+122.5%
Net profit	₹10.0	+755.9%	+171.4%
EPS (₹)	7.95	+783.3%	+180.9%
Operating margin	10.1%	—	—

Full quarterly financials → Results calendar →

FAIRCHEMOR delivery percentage

NSE end-of-day data for Fri, 16 Oct 2026

On Fri, 16 Oct 2026, 52.54% of the FAIRCHEMOR shares traded on NSE were taken to delivery, against the stock's own 20-session average of 42.97%. The price rose 1.16% on that unusually high delivery, the pattern the delivery dashboard labels accumulation. It closed at a price band (circuit) on 2 sessions in about the last 20.

52.54%Delivery, 16 Oct

42.97%Own 20-session average

0.8×Volume vs its average

₹767.35NSE close · +1.16%

Delivery in the last 5 sessions: 37.6% · 37.8% · 39.3% · 56.8% · 52.5%

Delivery across the market →Circuit stocks →

A description of what the exchange published, not a recommendation. Names such as "accumulation" or "long buildup" label a pattern in the numbers. How delivery is analysed

📢 Recent Corporate Announcements

Fairchem Organics Files Share Capital Audit Reconciling 1.26 Crore Demat Shares for Q2 FY27

🟡 NEUTRAL ⭐ 1/10

ROUTINE 📅 10 Oct 2026, 11:40 AM

Fairchem Organics Limited has submitted its Reconciliation of Share Capital Audit report under Regulation 76 of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026. The certificate, issued by M/s Prahlad L. Patel & Co., Chartered Accountants, reconciles 1,25,95,902 equity shares of face value Rs. 10 each held in demat form with NSDL and CDSL. This total includes 41,646 equity shares parked in a suspense/escrow account with CDSL. This is a standard quarterly compliance filing with no operational or financial impact.

Reconciliation covers 1,25,95,902 equity shares of Rs. 10/- each as of September 30, 2026
Includes 41,646 equity shares held in suspense/escrow account with CDSL
Audit certificate dated October 9, 2026 issued by M/s Prahlad L. Patel & Co., Chartered Accountants

💡 No action required. Investors should track upcoming quarterly financial results for operational performance updates.

Fairchem Organics Submits Demat Compliance Certificate for Q2 FY27

🟡 NEUTRAL ⭐ 1/10

ROUTINE 📅 07 Oct 2026, 10:52 AM

Fairchem Organics Limited has submitted its quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026. The certificate was issued by the Registrar and Transfer Agent, MUFG Intime India Private Limited. The company reiterated that 100% of its share capital has been in dematerialized form since the allotment on August 26, 2020. This is a standard quarterly administrative disclosure with no operational or financial impact.

Compliance certificate submitted for the quarter ended September 30, 2026
Confirmation certificate received from RTA MUFG Intime India Private Limited dated October 3, 2026
Entire share capital remains 100% in dematerialized form since August 26, 2020

💡 No action is needed as this is a standard statutory filing; investors should track upcoming Q2 FY27 financial results for operational updates.

Q1 FY27 Revenue up 34.4% YoY to Rs 176 Cr; EBITDA Margins Recover to 10.14%

🟢 POSITIVE ⭐ 8/10

EARNINGS 📅 30 Jul 2026, 04:25 PM

Fairchem Organics reported a strong start to FY27 with Q1 revenue of Rs 176 Cr, a 34.4% YoY increase. Profitability showed a sharp recovery with a PAT of Rs 10 Cr for the quarter, already exceeding the total TTM PAT of Rs 6 Cr. EBITDA margins improved to 10.14%, driven by higher price realizations and operational efficiencies, including a 30% reduction in power consumption. Management has provided a volume growth guidance of 15-20% for the full year FY27.

Revenue from operations grew 34.4% YoY to Rs 176 Cr in Q1 FY27.
EBITDA margin expanded to 10.14% (Rs 18 Cr), significantly higher than the FY26 OPM of 4.7%.
Management guided for 15-20% volume growth for FY27, targeting 5-7% growth per quarter.
Isostearic acid capacity utilization is targeted to reach over 80% within the next 1-2 years.
Operational costs reduced through a 30% cut in power consumption and 35% in solid fuel usage.

💡 Watch for the successful completion of European regulatory registrations (REACH) which is critical for the planned ramp-up of high-margin Isostearic acid exports.

Fairchem Organics Releases Q1 FY27 Earnings Call Audio Recording

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 28 Jul 2026, 05:31 PM

Fairchem Organics has released the audio recording of its earnings call held on July 28, 2026, regarding the unaudited financial results for the quarter ended June 30, 2026. The company is currently navigating a period of low profitability, with a TTM OPM of 4.7% and a TTM PAT of only ₹6 Cr. Investors are looking for updates on the strategic ramp-up of Isostearic Acid exports and European REACH compliance, which have been previously delayed. The stock currently trades at a high P/E of 199.7, suggesting the market is pricing in a significant recovery from current levels.

Earnings call conducted on July 28, 2026, at 04:00 p.m. IST
Focus on unaudited financial results for the quarter ended June 30, 2026
Company maintains a TTM revenue of ₹460 Cr against a market cap of ₹1,104 Cr
Management previously noted a 19.9% QoQ volume decline in late 2025 due to weak paint industry demand
Strategic focus remains on Isostearic Acid exports to Europe pending regulatory clearances

💡 Investors should access the recording to identify management's specific timeline for European REACH compliance and any commentary on margin recovery from the current 4.7% level.

755% YoY PAT Growth in Q1 FY27; Revenue up 34% to ₹176.49 Cr

🟢 POSITIVE ⭐ 8/10

EARNINGS 📅 28 Jul 2026, 01:04 PM

Fairchem Organics reported a robust Q1 FY27 with total income rising 34.5% YoY to ₹176.49 Cr. Net profit surged to ₹10.01 Cr from ₹1.17 Cr in the same quarter last year, representing a massive 755% increase. This quarterly revenue alone represents approximately 38.4% of the company's total TTM revenue of ₹460 Cr, indicating a significant acceleration in business activity. Basic EPS for the quarter improved to ₹7.95, which already exceeds the full-year FY26 EPS of ₹4.28.

Total Income from Operations reached ₹176.49 Cr, a 34.5% increase over Q1 FY26 (₹131.20 Cr).
Net Profit After Tax jumped to ₹10.01 Cr from ₹1.17 Cr in the year-ago period.
Earnings Per Share (EPS) for the single quarter rose to ₹7.95, compared to ₹0.90 in Q1 FY26.
Profit Before Tax (PBT) stood at ₹13.64 Cr, a significant recovery from ₹1.62 Cr YoY.
Quarterly revenue of ₹176.49 Cr is ~50% higher than the immediate preceding quarter (₹117.47 Cr).

💡 Investors should monitor the sustainability of these improved margins and check if the growth is driven by the previously delayed Isostearic Acid exports to Europe. Watch for the full quarterly report to assess if raw material costs or product mix shifts contributed to the 755% profit surge.

Fairchem Organics Shareholders Approve Re 1 Dividend and Re-appointment of Managing Director

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 28 Jul 2026, 12:40 PM

Fairchem Organics Limited has concluded its 7th Annual General Meeting (AGM) held on July 27, 2026, with shareholders approving all six proposed resolutions. Key approvals include the adoption of FY26 audited financial statements and the declaration of a final dividend of Re 1.00 per equity share (10% of face value). The re-appointment of Shri Nahoosh J. Jariwala as Managing Director was passed with 100% assent, ensuring leadership continuity. While most resolutions passed unanimously, the re-appointment of two directors saw a minor dissent of approximately 3.07% from voting shareholders.

Final dividend of Re 1.00 per equity share approved for the financial year ended March 31, 2026.
Re-appointment of Shri Nahoosh J. Jariwala as Managing Director passed with 100% assent (89,48,829 votes).
Minority dissent of 3.07% (2,75,056 votes) recorded against the re-appointment of Director Shri Sumit Maheshwari.
Total of 89,48,985 valid votes were cast via remote e-voting and e-voting during the AGM.
Remuneration for Cost Auditors for FY27 was ratified with 100% shareholder approval.

💡 Investors should monitor the dividend credit timeline and focus on the company's upcoming quarterly results to track the progress of Isostearic Acid exports to Europe, which remains the primary strategic growth driver.

Fairchem Organics Q1 FY27: PAT at Rs 10 Cr exceeds TTM total; Export target 50%

🟢 POSITIVE ⭐ 7/10

EARNINGS 📅 27 Jul 2026, 04:55 PM

Fairchem Organics reported a significant turnaround in Q1 FY27, with a PAT of Rs 10.0 Cr, which already exceeds the total TTM PAT of Rs 6 Cr. Revenue for the quarter reached Rs 176.1 Cr, representing approximately 38% of the TTM revenue, indicating a sharp recovery in operational performance. The company is aggressively targeting the export market, aiming to increase the export mix to 50% of total sales, supported by favorable US tariffs and proposed FTAs with the EU/UK. Despite a difficult FY26 where ROCE fell to 3.88%, the Q1 EBITDA of Rs 17.9 Cr suggests a potential margin expansion phase.

Q1 FY27 PAT of Rs 10.0 Cr is significantly higher than the total TTM PAT of Rs 6 Cr.
Q1 FY27 Revenue reached Rs 176.1 Cr, compared to the full FY25 revenue of Rs 537.9 Cr.
Strategic target set to increase export share from current levels to 50% of total sales.
Raw material sourcing remains niche, utilizing by-products that are only 1.25% and 0.25% of processed soft oils.
Completed a share buyback worth Rs 34 Cr in January 2026.

💡 Investors should monitor the sustainability of these improved margins in upcoming quarters and track the progress of European REACH regulatory compliance for Isostearic Acid exports.

Fairchem Organics Approves Re. 1.00 Dividend and Re-appoints MD at 7th AGM

🟡 NEUTRAL ⭐ 4/10

ROUTINE 📅 27 Jul 2026, 04:24 PM

Fairchem Organics concluded its 7th Annual General Meeting on July 27, 2026, where shareholders considered the adoption of FY26 financial results and a final dividend of Re. 1.00 per share (10%). A key resolution included the re-appointment of Shri Nahoosh Jariwala as Managing Director for a three-year term effective August 13, 2026. The company is currently operating with a low TTM operating margin of 4.7% and a TTM PAT of Rs 6 Cr. Voting results are expected within two working days of the meeting's conclusion.

Final dividend of Re. 1.00 (10%) per equity share declared for the financial year ended March 31, 2026.
Re-appointment of Shri Nahoosh Jariwala as Managing Director for a 3-year term from August 2026 to August 2029.
Re-appointment of Shri Sudhin Choksey as an Independent Director for a second 5-year term starting February 2027.
TTM revenue stands at Rs 460 Cr with a current market capitalization of Rs 1052 Cr.
Company is navigating a high P/E environment of 190.2 despite a low TTM PAT of Rs 6 Cr.

💡 Investors should monitor the official voting results for any significant shareholder dissent and track the timeline for dividend disbursement. The focus remains on the ramp-up of Isostearic Acid exports once European regulatory hurdles are cleared.

755% YoY PAT Growth: Fairchem Organics Reports Strong Q1 FY27 Results

🟢 POSITIVE ⭐ 7/10

EARNINGS 📅 27 Jul 2026, 12:53 PM

Fairchem Organics reported a sharp recovery in Q1 FY27, with revenue from operations reaching ₹176.15 cr, a 34.4% increase compared to ₹131.06 cr in Q1 FY26. Net profit surged to ₹10.01 cr from ₹1.17 cr in the year-ago period, representing a 755% YoY growth. The quarterly EPS of ₹7.95 has already exceeded the entire TTM EPS of ₹4.24, indicating a significant operational turnaround. This performance follows a period of subdued demand and regulatory delays in the European market.

Revenue from operations grew 34.4% YoY to ₹176.15 cr and 50.6% QoQ from ₹116.93 cr.
Net profit (PAT) reached ₹10.01 cr, a massive jump from ₹1.17 cr in June 2025.
Quarterly EPS stood at ₹7.95, compared to ₹0.90 in the same quarter last year.
Segment results for Specialty Chemicals improved to ₹15.47 cr from ₹2.62 cr YoY.
Finance costs increased to ₹1.84 cr from ₹1.01 cr in the year-ago quarter.

💡 Investors should monitor management commentary regarding the sustainability of these margins and the status of Isostearic Acid exports to Europe. The key factor to watch is whether this volume growth is a one-off recovery or a structural ramp-up following REACH compliance.

Fairchem Organics Schedules Q1-FY27 Earnings Conference Call for July 28, 2026

🟡 NEUTRAL ⭐ 2/10

EARNINGS 📅 14 Jul 2026, 02:34 PM

Fairchem Organics Limited has scheduled its Q1-FY27 earnings conference call for July 28, 2026, at 4:00 PM IST. The management, including the Managing Director and CFO, will discuss the unaudited financial results for the quarter ended June 30, 2026. This comes at a time when the company has a TTM revenue of Rs 460 Cr and a relatively low operating margin of 4.7%. Investors will be looking for updates on the recovery of margins and the status of Isostearic Acid exports to Europe.

Earnings conference call scheduled for July 28, 2026, at 04:00 PM IST.
Management representation includes Mr. Nahoosh Jariwala (MD & Chairman) and Mr. Bhavesh Shah (CFO).
The call will address financial performance for the quarter ended June 30, 2026.
Company currently operates with a TTM OPM of 4.7% and TTM PAT of Rs 6 Cr.
External advisor Valorem Advisors will coordinate the session.

💡 Investors should listen for management commentary regarding the timeline for European REACH compliance and the expected ramp-up of high-margin Isostearic Acid exports.

100% Dematerialized: Fairchem Organics Files Quarterly SEBI Compliance for June 30, 2026

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 06 Jul 2026, 10:12 AM

Fairchem Organics has submitted its quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations for the period ended June 30, 2026. The company's Registrar and Transfer Agent (RTA), MUFG Intime India, confirmed the processing of dematerialization requests. Notably, the company maintains that its entire share capital has been in dematerialized form since the initial allotment on August 26, 2020. Shares belonging to investors with missing demat details remain parked in an Unclaimed Suspense Account.

Compliance certificate issued for the quarter ended June 30, 2026
Entire share capital has been 100% dematerialized since August 26, 2020
Confirmation certificate provided by RTA MUFG Intime India on July 1, 2026
Unclaimed shares are held in a dedicated Suspense Account due to missing shareholder demat details

💡 This is a routine administrative filing. Investors should monitor the company's upcoming quarterly financial results for operational performance updates.

Rs 173.99 Cr: CARE Reaffirms 'CARE A; Stable' Rating; Long-term Bank Facilities Enhanced

🟡 NEUTRAL ⭐ 6/10

REGULATORY 📅 30 Jun 2026, 11:39 AM

CARE Ratings has reaffirmed Fairchem Organics' long-term credit rating at 'CARE A; Stable' and short-term rating at 'CARE A1'. A significant detail is the enhancement of rated long-term bank facilities from Rs 123.99 crore to Rs 173.99 crore. This Rs 50 crore increase in rated limits represents approximately 11% of TTM revenue and 19% of the current net worth, providing additional financial headroom. The reaffirmation comes despite a challenging period where OPM has moderated to 4.7% and TTM PAT stands at Rs 6 crore.

Long-term bank facilities rating reaffirmed at 'CARE A; Stable'
Short-term bank facilities rating reaffirmed at 'CARE A1'
Rated long-term bank facilities enhanced by Rs 50 crore to a total of Rs 173.99 crore
Total rated bank facilities (Long + Short term) now stand at approximately Rs 181.24 crore
Rating action follows an annual review by CARE Ratings Limited

💡 Monitor the utilization of the additional Rs 50 crore credit limit to see if it funds the strategic ramp-up of Isostearic Acid exports once European regulatory hurdles are cleared.

Fairchem Organics to Close Trading Window from July 1, 2026, for Q1 FY27 Results

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 23 Jun 2026, 04:13 PM

Fairchem Organics Limited has announced that its trading window for dealing in equity shares will be closed starting July 1, 2026. This action is taken in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, ahead of the declaration of unaudited financial results for the quarter ending June 30, 2026. The window will remain closed until 48 hours after the financial results are made public. The specific date for the board meeting to approve these results will be notified at a later date.

Trading window closure effective from July 1, 2026.
Closure pertains to the first quarter (Q1) ending June 30, 2026.
Window to reopen 48 hours after the announcement of unaudited financial results.
Compliance with Schedule B and Regulation 9 of SEBI Insider Trading Regulations.
Board meeting date for result approval to be intimated in due course.

💡 No action is required as this is a standard regulatory procedure. Investors should await the announcement of the board meeting date to assess the company's Q1 financial performance.

Fairchem Organics Issues Notice for AGM and Dividend TDS for FY 2025-26

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 10 Jun 2026, 01:56 PM

Fairchem Organics Limited has issued a formal notice to shareholders regarding its upcoming Annual General Meeting and the dividend payment process for the Financial Year 2025-26. The announcement focuses on the statutory Deduction of Tax at Source (TDS) on dividends and the requirement for shareholders to update their KYC details. Investors are urged to ensure their PAN, bank account, and nomination details are current to facilitate seamless dividend distribution. This is a standard regulatory update and does not reflect a change in company fundamentals.

Notice issued for the forthcoming Annual General Meeting (AGM) for the fiscal year 2025-26.
Detailed instructions provided regarding Tax Deducted at Source (TDS) on upcoming dividend payments.
Mandatory requirement for shareholders to update PAN, Email Address, Mobile Number, and Bank Account details.
Provision for shareholders to submit Form 15G/15H for tax exemption on dividend income where applicable.

💡 Shareholders should verify that their bank account and PAN are correctly updated in their demat accounts to ensure timely receipt of dividends. No immediate trading action is required as this is a routine administrative compliance notice.

Fairchem Organics Q4 FY26: PAT at ₹3.7 Cr; Targets 80% Capacity Utilization in FY27

🟢 POSITIVE ⭐ 7/10

EARNINGS 📅 09 May 2026, 01:42 PM

Fairchem Organics reported a 14.5% YoY decline in annual revenue to ₹460 crores for FY26, with a full-year net profit of ₹6.2 crores. Despite the annual dip, Q4 FY26 showed signs of recovery with EBITDA margins improving to 6.9% due to better domestic price realizations and reduced Chinese dumping. The company successfully completed a buyback of 4.25 lakh shares, increasing promoter holding to 63.2%. Management is optimistic about FY27, targeting 80% capacity utilization and an increase in export share from 9% to 20%.

FY26 revenue declined 14.5% to ₹460 crores, with Q4 revenue at ₹117 crores.
EBITDA margins improved to 6.9% in Q4 FY26, up from the full-year average of 4.7%.
Management targets 80% capacity utilization in FY27 and 95% within two years.
Export revenue share is projected to grow from the current 9% to approximately 20%.
Promoter holding increased from 61.2% to 63.2% following a buyback of 4.25 lakh shares.

💡 Investors should monitor the company's ability to scale capacity utilization and exports as guided, which could lead to significant operating leverage. The reduction in Chinese dumping and recovery in the paint industry are key positive triggers to watch.

View All FAIRCHEMOR Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

Total revenue from operations fell 13.45% in FY25 to INR 5,379 Mn from INR 6,215 Mn in FY24. In H1-FY26, revenue declined 20.1% YoY to INR 2,426 Mn due to weaker offtake from the paints industry and increased competition.

Geographic Revenue Split

Domestic sales accounted for 91.22% of revenue, while export sales contributed 8.78% during Q2-FY26. Exports are currently seeing slower-than-expected scale-up due to regulatory registration requirements in Europe.

Profitability Margins

Net Profit Margin fell from 6.52% in FY24 to 4.09% in FY25, and further collapsed to 0.78% in H1-FY26. This 512 bps YoY decline in H1-FY26 margins is attributed to substantial falls in overall sales and negative operating leverage.

EBITDA Margin

EBITDA margin was 3.87% in H1-FY26, a sharp decline of 618 bps from 10.05% in H1-FY25. Q2-FY26 EBITDA margin stood at 3.77%, down 251 bps YoY, reflecting lower volumes and higher fixed costs relative to sales.

Capital Expenditure

Capital work-in-progress increased from INR 60 Mn in FY24 to INR 137 Mn by H1-FY26. The company reported investing cash outflows of INR 255 Mn in FY25 and INR 106 Mn in H1-FY26 for capacity maintenance and expansion.

Credit Rating & Borrowing

The company's long-term bank facilities were downgraded in June 2025 to CARE A; Stable from CARE A+; Stable. Short-term ratings were downgraded to CARE A1 from CARE A1+. Finance costs fell 11.1% YoY in H1-FY26 to INR 16 Mn.

⚙️ Operational Drivers

Capacity Expansion

The company processed 11,492 MT and sold 10,469 MT during Q2-FY26. Volume terms declined 19.9% on a Q-o-Q basis, reflecting weaker demand from key customer segments like paints.

Raw Material Costs

Total expenses in H1-FY26 were INR 2,332 Mn, representing 96.1% of revenue. The fall in operating profit margin by 26% in FY25 was primarily due to the inability to pass on costs amidst falling sales and increased competition.

Manufacturing Efficiency

Manufacturing efficiency has been impacted by lower volumes, with Q2-FY26 sales volume falling 19.9% QoQ, leading to higher per-unit depreciation costs which rose 7.7% YoY to INR 28 Mn.

📈 Strategic Growth

Growth Strategy

Growth is focused on the strategic ramp-up of Isostearic Acid exports. While currently delayed by European regulatory compliance, the company expects a staggered ramp-up post-completion. Additionally, the Board approved a buyback of INR 34 Cr in Nov 2025 to optimize capital structure.

Products & Services

Specialty chemicals including Isostearic Acid and other organic chemicals primarily sold to the paints and coatings industry.

Brand Portfolio

Fairchem Organics.

New Products/Services

Isostearic Acid is identified as the key strategic growth product, intended to drive export revenue once European regulatory hurdles are cleared.

Market Expansion

Targeting the European market for Isostearic Acid exports; currently in the process of completing necessary regulatory registrations to enable a staggered ramp-up.

Market Share & Ranking

The company maintains a leadership position in the domestic market for its niche specialty chemical products.

Strategic Alliances

Fairfax India, through FIH Mauritius Investment Limited, holds a controlling 52.83% equity stake as of March 31, 2024.

🌍 External Factors

Industry Trends

The specialty chemicals industry is facing a period of subdued demand and heightened competition, leading to a 37% decline in net profit ratios for the company in FY25.

Competitive Landscape

The landscape is becoming more aggressive, with 'increased competition' specifically cited as a negative factor impacting the company's scale and profitability indicators.

Competitive Moat

The moat is built on a leadership position in niche products and long-standing relations with reputed customers. However, this moat is being challenged by increased competition, as evidenced by the 50% drop in Return on Net Worth to 7.39% in FY25.

Macro Economic Sensitivity

Highly sensitive to demand cycles in the domestic paint and coatings industry, which accounts for the majority of the 91.22% domestic revenue share.

Consumer Behavior

Shift toward lower inventory holding or reduced offtake by industrial consumers in the paint sector has led to a 27% decline in the company's debtors turnover ratio.

Geopolitical Risks

Trade barriers in the form of new regulatory registration requirements in Europe are currently hindering the strategic expansion of the export business.

⚖️ Regulatory & Governance

Industry Regulations

Operations are subject to GPCB (Gujarat Pollution Control Board) norms for effluent and air emissions. Export operations are currently restricted by European regulatory registration requirements.

Environmental Compliance

The company spent INR 1.38 Cr on CSR activities, representing 2% of average net profits. It utilizes GPCB-approved recyclers for hazardous waste disposal.

Taxation Policy Impact

The effective tax rate for H1-FY26 was approximately 32%, with INR 9 Mn tax paid on a PBT of INR 28 Mn.

Legal Contingencies

No fraud was reported by statutory auditors under section 143(12) of the Act. Internal control systems are reported as adequate and audited by a firm of Chartered Accountants.

⚠️ Risk Analysis

Key Uncertainties

The primary uncertainty is the timeline for European regulatory compliance for Isostearic Acid, which is critical for reversing the current revenue de-growth trend.